Annovera

Chemical Namesegesterone acetate and ethinyl estradiol vaginal system
Dosage FormVaginal system (intravaginal; 0.15 mg/day of segesterone acetate, 0.013 mg/day of ethinyl estradiol)
Drug ClassMiscellaneous
SystemFemale reproductive
CompanyTherapeuticsMD, Inc.
Approval Year2018

Indication

  • To prevent pregnancy in females of reproductive potential.
Last updated on 10/14/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Annovera (Segesterone Acetate and Ethinyl Estradiol Vaginal System) Prescribing Information 2018TherapeuticsMD, Inc., Boca Raton, FL